Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Policka

6 clinical trials in Policka, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Policka at a glance
6
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

6 trials in Policka

Open in trial search
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Arteriosclerosis

Not yet recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Arteriosclerosis

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Arteriosclerosis

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Policka

What the registry says about research in the country

01 Cardiovascular Research

Clinical trials focusing on cardiovascular disease prevention and treatment are exploring innovative therapeutic approaches. Studies aim to evaluate new medications for reducing major cardiovascular events in patients with established heart conditions.

  • Cardiovascular Event Prevention
  • Lipid Management
  • Vascular Disease Treatment

Research initiatives are particularly centered on patients with elevated lipoprotein levels and those at risk of serious cardiovascular events.

02 Atherosclerosis Studies

Dedicated research examining atherosclerotic cardiovascular disease treatments, with trials evaluating novel therapeutic agents for preventing heart attacks and strokes in high-risk populations.

  • Stroke Prevention
  • Heart Attack Risk Reduction
  • Cardiovascular Mortality

Studies specifically target patients with established vascular disease and elevated LDL cholesterol levels.

03 Preventive Cardiology

Comprehensive research programs investigating preventive therapies for cardiovascular complications, focusing on urgent coronary interventions and long-term cardiovascular health management.

  • Emergency Cardiac Care
  • Preventive Medicine
  • Cardiovascular Risk Management

These trials aim to advance understanding of various therapeutic approaches in cardiovascular risk reduction.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.